We have investigated the relationship of diet to plasma lipid and lipoprotein levels in 6494 hypercholesterolemic (Type MA) men who were instructed in an isocaloric, 400 mg cholesterol, 0.8 polyunsaturated-to-saturated fat ratio diet in the course of recruitment for the Lipid Research Clinics Coronary Primary Prevention Trial. Single 24-hour dietary recalls, plasma total and high density lipoprotein cholesterol, and total triglyceride determinations were obtained approximately 1 month before and 1 month after dietary instruction. Cross-sectional correlation analysis disclosed no significant association between diet and plasma cholesterol at entry. However, when diet-associated changes were similarly analyzed, weight loss, decreased intakes of saturated fat and cholesterol, and increased intake of polyunsaturated fat were all significantly and independently predictive of falls in plasma cholesterol, mainly in its low density lipoprotein fraction. The multiple correlation coefficient for the resultant four-variable regression model was 0.29. Diet-associated changes in plasma very low density lipoprotein cholesterol were less marked but in the same direction. These dietary changes were also weakly associated with a lowering of plasma high density lipoprotein cholesterol, while weight loss had an opposite effect of similar strength. When one takes into account the variability of dietary recall data, the observed diet-associated changes in plasma cholesterol were compatible with the findings of metabolic ward studies. (Arteriosclerosis
T he diet-heart hypothesis 12 attributes the high incidence of atherosclerotic coronary heart disease (ACHD) in developed countries largely to the consumption of diets rich in animal fats and cholesterol. The two components of this hypothesized causal relationship are: 1) diets high in animal fats raise levels of plasma cholesterol, particularly the low density lipoprotein (LDL) component; and 2) high plasma cholesterol levels are a major contributor to atherogenesis. Critics of the diet-heart hypothesis have questioned both propositions, the first on the grounds of the absence of consistent correlations between diet and plasma cholesterol levels in large cross-sectional epidemiologic studies, 3 " 8 the second on the grounds that clinical trials to date have failed to demonstrate that treating hypercholesterolemia alters the risk or clinical course of ACHD.^1 1 The Lipid Research Clinics (LRC) Coronary Primary Prevention Trial 12 was designed primarily to address the second issue. This report, based on the recruitment phase (July 1973-July 1976) of this Trial, addresses the relationship of diet to plasma lipids and lipoproteins in a free-living population of men aged 35 to 59 years with Type MA hyperlipoproteinemia.
The literature is replete with metabolic ward studies demonstrating the effects of dietary fats and cholesterol on plasma cholesterol under highly standardized but artificial conditions. 13 " 18 The two best known such studies, by Keys et al. 17 and Hegsted et al. 18 developed regression equations predicting the expected plasma cholesterol response in normal subjects to a given change in dietary intake of saturated fat, polyunsaturated fat, or cholesterol. These regression equations have been applied widely to epidemiologic studies, despite important departures of the design and methodology of such studies from the controlled setting of the metabolic ward. Relatively little is known about the specific effects of these dietary factors on the lipoprotein fractions. The responses of LDL cholesterol, the dominant plasma cholesterol fraction, and of very low densitylipoprotein (VLDL) cholesterol to diet mirror the response of total cholesterol. However, except for its strong positive correlation with alcohol intake, the response of plasma high density lipoprotein (HDL) cholesterol to diet has not been well characterized, and the literature contains conflicting results. 19 " 26 Despite the number of studies of diet and plasma cholesterol in the literature and the consistency of their findings, their applicability to free-living situations has been questioned 27 ' ffl due to the absence of corroborative findings in large epidemiologic studies like the Framingham Study. 3 Criticisms of this sort tend to overlook the considerable methodologic difficulties in measuring the diets of free-living subjects and in controlling for extraneous factors, as well as the biases inherent in cross-sectional correlational analyses. 26 ' 29~32 Yet, these criticisms cannot be ignored.
The findings of the National Diet-Heart Study 33 answer some of these criticisms. Subjects in five geographic centers were assigned to one of three dietary regimens, with modified-fat-containing foods provided through special commissaries. The lowering of observed mean serum cholesterol levels in each of the 15 groups paralleled those predicted by the Keys equation, 17 but were on the average only about 60% as great. A regression model based on the pooled results from nearly 1000 subjects showed trends in the direction predicted by the Keys equation, but much smaller in magnitude and only marginally significant. Weight loss (both acute and longterm) and initial serum cholesterol level were other significant predictors of serum cholesterol response.
Similar results were recently reported for replicate baseline measurements, conducted 1 year apart, in 1900 middle-aged men participating in the Western Electric Study. 3 * Although no dietary intervention was introduced between the two visits, a dietary score based on the Keys equation was significantly predictive of plasma cholesterol change among individual subjects (P = 0.64, r = 0.12). A weak (r = 0.08) but significant correlation of the Keys score with plasma cholesterol at intake was also found in these men, in contrast to the negative findings of most other cross-sectional epidemiologic studies. As in the Diet-Heart Study, weight change was also positively and highly significantly correlated with change in plasma cholesterol.
An acute lowering of plasma cholesterol and tnglyceride levels during periods of caloric restriction has been demonstrated in numerous studies, 3335 " 42 very few of which deal specifically with subjects with Type II hyperlipoproteinemia. 33 ' 35 It is difficult to sort out the effects of caloric restriction and fat restriction in many of these studies. Moreover, relatively few studies address the long-term impact of weight loss after a new stable weight has been achieved and maintained, and the findings differ. 33 " 37 ' 40 Thus, the question of whether adipose mass per se is a determinant of plasma lipid levels remains controversial. The acute and chronic effects of weight loss on plasma HDL cholesterol are also not consistent among the studies which have addressed this question/ 1 ' 42 In the present study, we attempt to provide additional evidence to demonstrate the effect of diet on plasma cholesterol in free-living populations. The LRC study obtained dietary intervention data on 6494 subjects, all of whom received the same dietary instructions. Moreover, the LRC Trial deals specifically with men aged 35 to 59 years with Type MA hyperlipoproteinemia. Thus, although other studies are more generalizable, the present study addresses, with considerable statistical power, the specific population for whom the issue of cholesterol lowering by diet is most germane. Finally, since plasma tnglyceride and HDL cholesterol levels were also measured, we can address dietary effects on lipoprotein cholesterol fractions.
Methods

The LRC Coronary Primary Prevention Trial
The LRC Trial was a double-blind, randomized, placebo-controlled clinical trial carried out in 12 collaborating geographic centers and designed to test the hypothesis that cholesterol-lowering therapy with the bile acid, sequestrant cholestyramine, reduces the incidence of ACHD in men with Type MA hyperlipoproteinemia. The screening phase of this Trial (Visits 1-4) included instruction at Visit 2 in a moderate cholesterol-lowering diet, which aimed for a polyunsaturated-to-saturated fat ratio of approximately 0.8 and a daily dietary cholesterol intake of 400 mg. The LRC Trial's design is described in detail elsewhere. 12
Subjects
The study population consists of 6494 men who were eligible for the first three screening visits of the LRC Coronary Primary Prevention Trial and who had complete data at these visits for weight, height, plasma total and HDL cholesterol, plasma triglyceride, and 24-hour intake of total calories, saturated and polyunsaturated fat, and cholesterol. 12 Eligibility criteria included age (35 to 59 years), plasma lipid profile (total cholesterol =s 265 mg/dl, LDL cholesterol 2! 190 mg/dl, total triglyceride =£ 300 mg/dl at initial screening; absence of chylomicrons and floating beta-lipoprotein at Visits 1 and 2), and absence of clinically manifest ACHD, other heart disease, hy-pertension, obesity, renal disease, hepatic disease, thyroid disease, hyperuricemia, and significantly lifeshortening conditions. 12
Data Collection, Processing, and Analysis
Plasma total and HDL cholesterol and total triglyceride were measured at each visit on blood samples drawn after a 12-hour fast in core laboratories at each of the 12 Lipid Research Clinics. 43 " 45 We used the empirical approximation for VLDL cholesterol as 1/5 x plasma triglyceride, when plasma triglyceride was equal to or less than 400 mg/dl, and estimated LDL cholesterol by subtraction of HDL and VLDL from total cholesterol.' 46 This relationship was confirmed at Visit 2, when VLDL and LDL cholesterol values were also derived from cholesterol determinations for the d > 1.006 and d < 1.006 ultracentrifugal fractions. 43 Quality control was monitored by the Center for Disease Control in Atlanta, Georgia.
Dietary intakes were based on interviews obtained at Visits 1 and 3 at each clinic by dietitians specifically trained for the project who asked subjects to recount in detail all food consumed during the 24-hour period immediately preceding the overnight fast. 47 These recalls were processed by the Nutrition Coding Center at the University of Minnesota, where food tables were used to compute nutrient intakes for each person's recall.
All additional data processing and all data analyses were performed at the Central Patient Registry and Coordinating Center at the University of North Carolina.
Timing of Visits
Prerandomization Visits 1-3 were scheduled at least 3 weeks apart, with a median interval of 32 days between visits. However, lapses of several months between visits were possible, and the Visit 1 to Visit 3 interval exceeded 90 days in approximately 18% of the subjects.
Linear Modelling Procedures
Linear Regression
All linear regression models were computed by least squares (SAS PROC STEPWISE and PROC GLM). 48 Both backward and forward stepwise procedures were used to assess the significance and partial correlation coefficients of the following potential predictors of plasma cholesterol change: changes from Visit 1 to 3 in Quetelet Index, total caloric intake, dietary cholesterol in mg/1000 calories, and saturated fat, monounsaturated fat, polyunsaturated fat, total carbohydrate, and alcohol intakes (all expressed as percentage of total caloric intake), and the baseline (Visit 1) values of each of these measurements as well as of plasma total and HDL cholesterol and total triglyceride. All predictor variables retained in the model had a p < 0.001. Other significant predictors of plasma cholesterol change (Including base-line plasma lipid-lipoprotein levels and alcohol intake) were taken as covariables in stratified analyses.
For each of the variables in the final model, the appropriateness of the linear model was assessed by grouping all subjects into deciles on the predictor variable and then comparing a plot of the mean plasma cholesterol change versus the mean value of the predictor variable for each decile to the univariate regression line for that variable. When the linear fit was poor, polynomial regression (with orthogonal polynomials) was used to achieve an adequate fit. A similar procedure was used for the multivariate regression lines, which were compared with the corresponding covariance-adjusted decile-specific mean changes in plasma cholesterol.
Stratified Analysis
Interactions among the predictor variables in the final model for plasma cholesterol change were assessed by classifying each subject according to each of the four variables in this model as either "positive change" or "negative change," and using SAS PROC GLM to perform an analysis of variance on the full (15-term) interaction model defined by all possible products of these four binary variables.
Stratified analysis was also used to assess the degree of confounding and/or effect modification by a series of covariables on the model for plasma cholesterol change. In each case the subjects were stratified on the covariable (2 to 12 strata per covariable), and SAS PROC GLM was used to calculate an intercept and regression coefficients for each of the four predictor variables within each stratum. Covariables were examined one at a time to assure that all strata contained enough subjects to permit reasonably precise estimates of these factors.
Multivariate Analysis
To examine simultaneously the effects of diet on plasma total and HDL cholesterol and total triglyceride and to obtain meaningful significance levels, canonical correlations 49 of this triad of measurements with the set of dietary predictor variables described above were calculated for Visit 1, Visit 3, and for the change between these two visits. These correlations were used in conjunction with stepwise regression procedures in arriving at an optimal linear model for plasma cholesterol change. Canonical correlations were also computed for logarithmically transformed plasma lipid-lipoprotein data; these differed little from those computed for the untransformed data.
Results
Changes from Visit 1 to Visit 3 in mean plasma lipid and lipoprotein levels, mean dietary intake values, and mean body weight and Quetelet Index are shown in table 1. Note that the LRC subjects achieved the desired polyunsaturated to saturated fat (P/S) ratio at Visit 3 and considerably surpassed the targeted restriction (400 mg/day) of dietary cholesterol. The latter achievement is not surprising in view of the unexpectedly low mean reported baseline intake of dietary cholesterol. This finding may be due to the prevalence of fat-modified diets in our subjects, to underrepresentation of weekend recall periods, and to general trends toward lower consumption of eggs and butterfat in the United States. 50 Although the LRC diet was not intended for weight reduction, the subjects reported that they consumed 11.5% fewer calories at Visit 3 than at Visit 1 and on the average had lost 0.7 kg of body weight. These dietary changes were accompanied by a 23.5 mg/dl lowering of mean plasma cholesterol levels, of which 21.6 mg/dl was in the LDL fraction and 1.4 mg/dl was in the HDL fraction, and a 2.6 mg/dl lowering of mean plasma triglyceride levels. Table 1 also indicates that a substantial lowering (7.9 mg/dl) of mean plasma cholesterol levels occurred between Visits 1 and 2, before any dietary instruction was given. In the absence of dietary recall data at Visit 2, one could speculate that some subjects altered their diets after their initial LRC visit without waiting for formal dietary instruction; however, statistical regression to the mean is sufficient to account for this entire change. 51 Since regression to the mean can produce a change in mean plasma cholesterol only for time intervals in which the initial plasma level is a criterion for continuation in the study, this statistical phenomenon cannot have contributed to the 15.6 mg/dl decline in mean plasma cholesterol levels observed between Visits 2 and 3. Similarly, regression to the mean may account for the small rise in mean plasma triglyceride levels between Visits 1 and 2.
To determine the degree to which plasma lipid and lipoprotein changes between Visits 1 and 3 could be attributed to the observed quantitative and qualitative dietary changes, we took a linear modelling approach. Canonical correlations analysis identified the dominant association of change in plasma total cholesterol (C) primarily with changes in Quetelet Index (Ql), in g/cm 2 , 24-hour intakes of saturated fat (SF) and polyunsaturated fat (PF), as percentage of calories, and of cholesterol (DC) in mg/1000 calories; the canonical correlation coefficient was 0.32. Regression analysis affirmed that the following model had the multiple correlation coefficient 0.29, and thus accounted for nearly all the measured dietrelated variation in plasma cholesterol change:
The dependence of AC on each of these predictor variables is illustrated in figure 1 . Decreases in Quetelet Index and in saturated fat intake are each strong independent predictors of decreases in plasma cholesterol levels, while increases in polyunsaturated fat and decreases in dietary cholesterol intake are relatively weak predictors of decreases in plasma cholesterol levels. Note also that while the latter three relationships appear to be adequately described by straight lines, the dependence of plasma cholesterol change on change in Quetelet Index (figure 1 A) is distinctly nonlinear, with flattening at the positive and negative extremes of Quetelet Index change. A fifth degree polynomial in Quetelet Index change (AQ) was needed to provide a reasonable fit of the data; however, for most of our subjects, this polynomial is well approximated by its linear term. It is possible that some large gains or losses in weight reflect measurement errors or changes in body water content, and are therefore not proportionately associated with plasma cholesterol change.
Since weight changes and dietary changes arising from a single dietary intervention are likely to be correlated with one another and might interact in a complex manner, we did some additional analyses to sort out these effects. Simple univariate regressions (table 2, part 1) of plasma cholesterol change on AQ, ASF, APF, and ADC all gave substantially higher coefficients than their counterparts in the multiple regression model defined above; this indicates some overlap in the predictiveness of these variables. However, a stratified analysis of the effect of dietary change on plasma cholesterol in three categories of weight change (table 2, part 2B) demonstrated the independence of these effects. Within each stratum of weight change, even in nearly 3000 men whose weights remained virtually constant between Visits 1 and 3, the ASF, APF, and ADC values were all predictive of plasma cholesterol change, in agreement with the unstratified analysis. Although there was a tendency for the coefficients to be larger among the men who lost weight, this tendency was not statisti- 'Summary (weighted by No.) and stratum-specific regression coefficients are given for a series of stratified analyses. tp =£ 0.05 for heterogeneity among strata. $p < 0.001 for heterogeneity among strata. Ql = Quetelet Index; SF = saturated fat; PF = polyunsaturated fat; DC = cholesterol. cally significant in any case. Moreover, there was a clear and highly significant (p < 0.0001) difference among intercepts, which confirmed the strong association of weight loss with decreases in plasma cholesterol levels. Comparison of the weighted average of the stratum-specific results with the regression model for all 6494 men (table 2, part 2A) shows that only the coefficient for ASF is appreciably confounded by weight change. Finally, a stratified analysis was done to assess the statistical interactions of all possible combinations of AQI, ASF, APF, and ADC and no significant interaction effects were found.
Since there was considerable heterogeneity other than diet changes among the 6494 men in these analyses, we performed a series of analyses to control for additional variables that might confound or modify the apparent effects of dietary and weight changes on plasma cholesterol (table 2, part 3). Although the variables of educational level, clinic, alcohol intake, baseline lipids, and the number of days between Visits 1 and 3 all were significantly associated with plasma cholesterol change, there were only two instances (ASF and alcohol, ASF and plasma triglyceride) in which regression coefficients differed significantly (p < 0.05) among strata. None of the 36 potential interactions that we examined met the more stringent significance criterion p < 0.0013 (Bonferroni adjustment) for multiple tests. The excellent agreement of the weighted averages of the stratumspecific coefficients with the coefficients in the simple four-variable model (table 2, part 3A) demonstrates that none of the nine covariables examined were confounders in this model.
The reader may also note that the intercept term for the stratum with high plasma cholesterol at Visit 1 is substantially more negative (p < 0.0001) than that for the low-cholesterol stratum. This effect is due to statistical regression to the mean 52 and cannot be taken as evidence that men with higher plasma cholesterol are more responsive to diet. On the other hand, the difference in intercepts between the high and low Visit 1 plasma HDL cholesterol strata indicates that men with higher HDL cholesterol levels were apparently likelier to reduce their plasma cholesterol, irrespective of AQI, ASF, APF, and ADC. The explanation for this effect is unknown.
The large intercept terms in all the regression models described in table 2 also deserve some comment. A negative intercept term implies that a decrease in plasma cholesterol levels between Visits 1 and 3 is predicted even for men who made no change in diet and lost no weight. This result is due, at least in part, to statistical regression to the mean, 51 arising from the exclusion at Visit 1 of subjects with plasma cholesterol below 265 mg/dl. This problem could have been avoided by examining plasma cholesterol changes between Visits 2 and 3. However, since dietary recalls were not obtained at Visit 2 and since regression models using Visit 2 as the baseline for plasma cholesterol and Visit 1 as the baseline for diet and weight were distorted by spontaneous dietary modifications and weight loss which occurred between Visits 1 and 2, we could do such an analysis only for Quetelet Index (figure 2). Note that the curve depicting the association of Quetelet Index change with plasma cholesterol change between Visits 2 and 3 is virtually parallel to the comparable curve for Visits 1 and 3, but that its intercept is approximately 7 mg/dl closer to zero. One would expect to see similar effects for each of the dietary variables and for the full LRC model, although we have no data which address this issue directly.
Rather than dwell on interaction, confounding, and statistical tests of significance, however, it is useful to take a broader look at the results in table 2. Virtually every group identified, some containing fewer than 400 subjects, tells basically the same story. Weight reduction, decreased intake of saturated fat and cholesterol, increased intake of polyunsaturated fat all are predictive of decreases in plasma cholesterol levels in nearly every stratum. The quantitative differences among strata, although interesting and even statistically signifi- cant in some cases, should not be allowed to obscure the overall consistency and the general applicability of our basic four-variable regression model in our study population.
To compare the performance of standard dietary indices based on the studies by Keys et al. 17 and Hegsted et al. 18 in the LRC data to that of the internally fitted model, we computed a regression model, the "LRC index," based only on changes in dietary intake from Visits 1 to 3 ( summarized by the LRC index, are associated with parallel changes in the three lipoprotein cholesterol fractions, with the LDL effect predominant (figure 3 A). However, when weight change is incorporated into the model (figure 3 B) , a greater proportion of the predicted plasma cholesterol change is associated with the VLDL fraction, while virtually none is associated with the HDL fraction. Thus, weight loss tends to offset the slight fall in HDL cholesterol associated with the recommended modifications of dietary fat intake, while complementing the lowering of LDL and VLDL cholesterol associated with these modifications. The results of cross-sectional analysis of the association of diet and plasma cholesterol are compared with the longitudinal analysis in table 4. Note that the association is much weaker in cross section than longitudinally and is, in fact, in the "wrong" direction at Visit 1. The same pattern is apparent when the associations of SF, PF, and DC with plasma cholesterol are examined individually. Moreover, canonical correlations analysis failed to demonstrate any linear combination of dietary variables and Quetelet Index that was significantly associated with plasma cholesterol at Visit 1, after controlling for the associations of plasma HDL cholesterol with alcohol intake and of plasma triglyceride with Quetelet Index. Some possible reasons for these results will be discussed.
Discussion
Much has been written about the shortcomings of the 24-hour recall as a meaningful epidemiologic measure of exposure to dietary factors. 29 " 32 First, the subject's recall is often incomplete or inaccurate. Second, even an accurate 24-hour recall may not be representative of a subject's habitual diet. Finally, the subject's habitual diet may have been modified in response to previous dietary counseling for hyperlipoproteinemia or obesity. The first two of these sources of error are likely to occur randomly. However, the last is likeliest to occur in subjects with the highest baseline plasma cholesterol levels and thereby tends to introduce a bias associating high levels of plasma cholesterol with cholesterol-lowering diets. Moreover, it is often not appreciated that even random variation may suppress the magnitudes of correlation and regression coefficients. Beaton et al. 30 demonstrated that the variance of 24-hour dietary recall measures like saturated fat, polyunsaturated fat, and cholesterol intake (normalized to total caloric intake) among serial observations in individual subjects can easily exceed the variance of these measures among different subjects. The greater the ratio of intrasubject to intersubject components of variance (VR), the more severely the observer will underestimate the true degree of association of these variables with plasma cholesterol. The regression coefficient for a given predictor variable is underestimated by a factor of 1 + VR. This bias cannot be alleviated by increasing the number of subjects in the study -only by increasing the precision of each observation (e.g., by making each observation the average of several one-day recalls) or by recruiting a group of subjects with more dietary heterogeneity.
These factors mitigate strongly against finding associations of plasma cholesterol with diet cross-sectionally at Visit 1. The variance ratios for the dietary variables of interest are likely to be as unfavorable as those reported by Beaton et al. Moreover, many subjects, especially those whose cholesterol levels caused them to come under a physician's care, had been exposed to dietary counseling before Visit 1; some, in fact, were known to be on highly restricted diets. When one further considers the possible genetic and other nondietary factors which may account for baseline differences among subjects in plasma cholesterol, the failure of this and other cross-sectional studies to reproduce metabolic ward results is not surprising. In fact, it is surprising when, as in the Western Electric Study, 34 the "expected" relationships are found cross-sectionally.
The impact of variable prior exposure to dietary intervention on the cross-sectional analysis at Visit 1 is illustrated by performing the same analysis at Visit 3, at which time all subjects were following the same dietary instructions. With this source of bias effectively eliminated, one is able to demonstrate small but significant associations of diet with plasma cholesterol in directions consistent with metabolic ward results, despite the facts that these analyses do not control in any way for genetic and other non-dietrelated differences among subjects and that they are unlikely to lower the ratio of intrasubject to intersubject variance or remove the resulting bias.
An analysis of the association of plasma cholesterol changes from Visit 1 to Visit 3 with concurrent changes in diet and Quetelet Index (thereby "adjusting" for each subject's baseline status) removes much of the "noise" arising from non-diet-related determinants of plasma cholesterol and helps unmask the contributions of dietary factors. Therefore, this mode of analysis is far better suited than cross-sectional analysis for demonstrating these relationships. However, the coefficients for the dietary variables in the LRC index are still considerably lower than their counterparts in the Keys and Hegsted equations. For example, one must multiply the coefficients for changes in intake of saturated fat, polyunsaturated fat, and cholesterol in the LRC dietary index by 2.6, 3.9, and 10.1, respectively, to achieve congruity with the Hegsted index, where the conversion factor 2.24 (0.001 times the average caloric intake at Visits 1 and 3) has been used to adjust the coefficients for dietary cholesterol in the two indices to the same units. Since replicate dietary recall data were not obtained for Visit 1 or Visit 3, we cannot assess directly whether disparities of this magnitude can reasonably be attributed to high ratios of intrasubject to intersubject variance in these measurements. However, Beaton et al., 30 using LRC methodology and a cross-sectional (no intervention) design, found variance ratios of 3.2, 5.3, and 13.2 for these three dietary variables in normal males. Although one cannot extrapolate confidently from cross-sectional data in normal subjects to intervention data in hypercholesterolemic subjects, it appears that imprecision of dietary recall data may indeed be insufficient to suppress the Keys and Hegsted coefficients to values of similar magnitude to those observed in the LRC data.
Suppression of the regression coefficients for dietary intakes of saturated and polyunsaturated fat and cholesterol due to variability of the dietary recall data may also help account for the large intercept terms in the LRC model. If the Keys or Hegsted equation accurately predicted plasma cholesterol change from Visit 1 to Visit 3, dietary changes would have accounted for a 10.4 mg/dl or 15.9 mg/dl decrease, respectively, in mean plasma cholesterol. An additional decrease of at least 2.4 mg/dl, the difference between the mean change in plasma cholesterol accounted for by the LRC dietary index and that accounted for by the full LRC model, is attributable to change in Quetelet Index. (If there was appreciable within-subject error in measuring AQ, this estimate might also be too low.) Statistical regression to the mean, 51 as we have already seen, may be responsible, additionally, for a decrease of as much as 7.9 mg/dl in mean plasma cholesterol (the change observed from Visit 1 to Visit 2). When these effects are combined, the entire 23.5 mg/dl decrease in mean plasma cholesterol between Visits 1 and 3 can be reasonably accounted for. Of course, these arguments do not in any sense "prove" that the Keys or Hegsted model really underlies the observed response of plasma cholesterol to diet in the LRC study. They simply establish that neither the small magnitude of the regression coefficients nor the large intercept terms in the LRC model can be taken to refute the Keys or Hegsted model; imprecision of the dietary recall measures and regression to the mean are plausible explanations for these apparent discrepancies. These factors preclude attributing quantitative external validity to models based on the LRC data. The Keys and Hegsted equations provide the best estimates of the effect of diet on plasma cholesterol; the LRC data are qualitatively consistent with these equations.
Having addressed both the plausibility and limitations of the LRC model for the effects of dietary and weight changes on plasma cholesterol, let us explore its implications. The most striking is the importance of weight change. LRC subjects were not counseled to lose weight, and the interval between Visits 1 and 3 was only 2-3 months for most subjects. The average weight loss was only 0.7 kg. Thus, the LRC Trial was far from an ideal setting for exploring effects of weight loss. Yet weight loss was still found to be the most powerful predictor of plasma cholesterol change. If this effect of weight loss is sustained, as suggested by the findings of the Diet-Heart Study, 33 then weight reduction ought to play an expanded role in the treatment of Type MA hyperlipoproteinemia.
Another interesting feature is the effect of weight loss and of changes in qualitative dietary indices on the lipoprotein fractions ( figure 3) . Decreases in the qualitative dietary indices are predictive not only of decreases in the cholesterol associated with the "atherogenic" plasma lipoproteins LDL and VLDL, but in HDL cholesterol as well. This negative impact on HDL cholesterol is not of sufficient magnitude to negate the presumed beneficial impact of the other lipoprotein changes on ACHD risk but is statistically significant. However, weight loss, while complementing the dietary effects on LDL and VLDL cholesterol, offsets the adverse effects on HDL. Since fatcontrolled diets are often associated with weight loss even when this is not their intent (as was the case in the LRC Trial), failure to control for this factor may account for the apparent inconsistency in the literature on the impact of dietary fats and cholesterol on plasma HDL cholesterol. At any rate, the "beneficial" effect of weight loss on HDL cholesterol is another argument for its increased role in treatment of Type IIA hyperlipoproteinemia.
Conclusions
The data from the prerandomization dietary intervention in the LRC Coronary Primary Prevention Trial demonstrate unambiguously that weight loss, decrease in saturated fat intake, increase in polyunsaturated fat intake, and decrease in cholesterol intake all independently lower plasma cholesterol. The same is true of all plasma lipoprotein cholesterol fractions except HDL, which increases with weight loss. We have explored the methodologic problems which obscure these relationships in cross-sectional studies, and have shown how some (but not all) of these problems are alleviated in the analysis of dietary intervention data. Even when intervention data are used, relationships established in metabolic wards do not hold quantitatively in the LRC study. However, the quantitative discrepancies between the LRC results and these relationships are in line with the expected effects of imprecision in the 24hour dietary recall data and in the measured change in Quetelet Index and that of statistical regression to the mean. As long as the 24-hour recall is the instrument of dietary measurement, such discrepancies between epidemiologic and metabolic ward studies are to be expected and cannot be said to invalidate the application of the Keys and Hegsted models in free-living populations.
